Joseph joined CBSSM as a Research Area Specialist in November 2017. As a project manager, he coordinates the daily operations of Dr. Jeffrey Kullgren’s project “Provider, Patient, and Health System Effects of Provider Commitments to Choose Wisely,” a grant funded research project using novel approaches to reduce the overuse of low-value services in healthcare.
Page not found
Funded by Agency for Health Care Research and Quality.
Funding years 2010-2013.
We propose to develop and evaluate in a randomized controlled trial a computer tailored intervention to assist community health workers (CHWs) or other outreach workers to provide personalized patient education materials on oral anti-hyperglycemic medications and insulin to low-literacy, diabetic African American and English and Spanish-speaking Latino adults with poor glycemic control. For more information, visit NIH Reporter.
PI(s): Mary Heisler
Co-I(s): Michael Spencer, Melissa Valerio, Caroline Richardson, Angela Fagerlin, Lawrence An, Ananda Sen
Funded by Brigham and Women's Hospital/Boston Univerity/NIH.
Funding Years: 2010-2013.
In this continuation of the REVEAL Study, we will conduct a new randomized clinical trial to determine the psychological and health behavior changes associated with disclosing APOE genotype and 3-year Risk estimates to persons with mild memory problems. We will also create a new instrument that clinicians and researchers can use to reliably evaluate a patient's capacity to consent to genetic testing and examine long-term impact of genetic Risk assessment by following REVEAL Study patients 2-10 years following disclosure. For more information, visit NIH Reporter Link.
PI(s): J. Scott Roberts
Funded by Department of Veterans Affairs
Funding Year: 2012
Successful diabetes management is dependent on the patient - provider partnership. However, a full discussion of potential benefits, harms, costs, and burdens associated with each medication option is often too much for a brief clinic visit. This project uses AHRQ-developed consumer guides as inspiration for a tailored program that assists with this decision-making. The current iDECIDE intervention serves as the base of the program, with updates geared toward making it more specific to veterans.
Aim 1: Update current iDECIDE program to make it more appropriate for the VA setting.
Angela Fagerlin (PI)
Gina Bravo was a Visiting Scholar at CBSSM, 2011-2012. She has a PhD in mathematics and post-doctoral training in clinical epidemiology. Professor of Public Health at the University of Sherbrooke since 1991, she teaches research methods and biostatistics to MSc and PhD candidates. She is a member of the Research Centre on Aging located within the University Institute of Geriatrics of Sherbrooke. She has received personal research awards and peer-reviewed grants from the Quebec Health Research funding agency and the Canadian Institutes of Health Research.
Funded by the American Cancer Society
Funding Years: 2006-2011
This study examines the impact of "status-assessing" email messages sent to individuals who decided to quit smoking and chose a date to quit. Participants receive email messages 3 and 5 weeks after their self selected quit dates, asking them to click on a URL link that matches their current smoking status (quit, tried but relapsed, never quit). Participants who click on a link receive information targeted to their current smoking status.
PI: Brian Zikmund-Fisher, PhD
Funded by the National Institutes of Health
Funding years: 2008-2013
The specific aims are: 1) To test the effectiveness of a preference-tailored (PT) vs. standard information (SI) intervention for increasing primary care patient's CRC screening adherence in a randomized controlled trial at two locations; 2) To assess the impact of the intervention on informed decision making, knowledge and attitudes toward screening, decisional outcomes, and intention to get screened; and 3) To conduct a cost effectiveness analysis of the PT intervention for increasing CRC screening. For more information, visit NIH Reporter.
PI: Sarah Hawley
Co-Is: Angela Fagerlin, Victor Strecher
CBSSM's Co-Director Angela Fagerlin, Ph.D., has been named one of "25 Champions of Shared Decision Making." According to the Informed Medical Decisions Foundation, "Angie has spent her career testing methods for communicating the risks and benefits of treatment options to patients, especially through decision aids. Based on the knowledge she has gained, Angie developed and tested decision aids for prostate cancer and breast cancer prevention. Her work has truly advanced the field of risk communication and patient-physician communication."
Congratulations Angie! You can view the list here.